🇺🇸 LLY — Eli Lilly and Company

Healthcare Compra
← Volver

Precio actual

1.149,36 USD

Máx. histórico

1.292,65

16 días

Split 2:1 del 16/10/1997

Caída desde máximo

-11,08%

Rango 52 semanas

712,05 – 1.292,65

Variación hoy

-0,88%

Cierre anterior

1.159,60

Rango de hoy

1.138,31 – 1.158,43

Volumen hoy

2.159.931

Información
Nombre completo
Eli Lilly and Company
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
50.000
PER ⓘ
38,61 (puede no estar actualizado)
Dividend yield
0,60% (puede no estar actualizado)
Precio objetivo analistas
1.315,56 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 3 días
Sobre la empresa

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; and BioArctic AB (publ) for new treatment. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Dividendos repartidos Total últimos 12 meses: 6,6900 USD · Yield: 0,58%
Fecha de pago Importe por participación
13/08/1996 0,1710 USD
13/05/1996 0,1710 USD
13/02/1996 0,1710 USD
13/11/1995 0,1713 USD
11/08/1995 0,1613 USD
09/05/1995 0,1613 USD
09/02/1995 0,1613 USD
08/11/1994 0,1563 USD
09/08/1994 0,1563 USD
09/05/1994 0,1563 USD
09/02/1994 0,1563 USD
08/11/1993 0,1513 USD
09/08/1993 0,1513 USD
10/05/1993 0,1513 USD
09/02/1993 0,1513 USD
Splits Registrados en el histórico de precios
Fecha Ratio
16/10/1997 2:1
21/12/1995 2:1
01/05/1989 2:1
30/01/1986 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/04/2004 68,95 69,17 68,32 69,15 +0,66% 1,23% 3.705.400
02/04/2004 68,80 69,40 68,45 68,70 +1,63% 1,38% 4.923.500
01/04/2004 67,40 67,93 67,01 67,60 +1,05% 1,36% 5.346.400
31/03/2004 67,50 68,36 66,80 66,90 +1,67% 2,31% 5.951.000
30/03/2004 66,00 66,18 65,39 65,80 +0,30% 1,20% 3.444.300
29/03/2004 65,25 66,07 65,17 65,60 +0,92% 1,38% 4.241.400
26/03/2004 65,40 65,68 64,65 65,00 -0,76% 1,57% 5.019.500
25/03/2004 66,49 66,49 64,51 65,50 -1,49% 2,98% 6.332.700
24/03/2004 67,65 67,77 66,04 66,49 -1,57% 2,56% 4.967.000
23/03/2004 68,24 68,75 67,51 67,55 -0,60% 1,82% 3.193.600
22/03/2004 68,63 69,23 67,74 67,96 -0,98% 2,17% 3.264.000
19/03/2004 69,42 69,66 68,54 68,63 -1,70% 1,61% 3.000.700
18/03/2004 69,30 70,17 69,02 69,82 -0,01% 1,66% 2.888.300
17/03/2004 70,55 70,57 69,35 69,83 -1,19% 1,73% 3.435.900
16/03/2004 70,00 70,97 70,00 70,67 +1,42% 1,39% 3.043.600
15/03/2004 70,34 70,51 69,40 69,68 -1,76% 1,58% 3.090.500
12/03/2004 69,60 70,93 69,34 70,93 +2,54% 2,28% 3.059.000
11/03/2004 70,48 70,70 69,00 69,17 -1,87% 2,41% 3.918.700
10/03/2004 71,90 71,98 70,34 70,49 -1,89% 2,28% 3.915.300
09/03/2004 72,87 73,10 70,78 71,85 -1,30% 3,18% 4.915.200
08/03/2004 73,60 73,98 72,71 72,80 -0,90% 1,73% 1.997.000
05/03/2004 73,00 73,83 72,73 73,46 +0,46% 1,51% 2.249.500
04/03/2004 73,15 73,17 72,18 73,12 +0,05% 1,35% 2.070.700
03/03/2004 72,60 73,18 71,79 73,08 +0,62% 1,91% 1.630.500
02/03/2004 73,30 73,80 72,23 72,63 -1,10% 2,14% 1.881.600
01/03/2004 73,85 73,85 72,95 73,44 -0,68% 1,22% 3.299.300
27/02/2004 73,46 74,46 70,00 73,94 +0,46% 6,07% 3.223.500
26/02/2004 73,05 73,63 72,96 73,60 +1,11% 0,92% 2.452.700
25/02/2004 72,62 72,86 72,39 72,79 +0,58% 0,65% 2.678.600
24/02/2004 71,96 72,50 71,43 72,37 +0,49% 1,49% 2.661.300